Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part II—The Challenge of Programmed Death Ligand-1 Testing and Its Role in Microsatellite Instability-High Colorectal Cancer
Esmeralda Celia Marginean(BC Cancer Agency), Barbara Melosky(BC Cancer Agency)
Cited by 38
Related Papers
P1.01-28 Impact of Afatinib Dosing on Safety and Efficacy Real-World in Patients with EGFR Mutation-Positive Advanced NSCLC
|Journal of Thoracic Oncology|2018|1
Impact de la dose d’afatinib sur la tolérance et l’efficacité en vie réelle chez des patients avec CBNPC avancé EGFR muté
|Revue des Maladies Respiratoires|2018|0